Darzalex Approved for Multiple Myeloma

MONDAY, Nov. 16, 2015 — The injected chemotherapy drug Darzalex (daratumumab) has been approved by the U.S. Food and Drug Administration to treat people who have had at least three prior treatments for multiple myeloma, a form of blood cancer.
The…
Source: Topamax